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abstract
Introduction: Coronary artery disease is one of the most common causes of mortality 
around the world. The association between vitamin D deficiency and the incidence 
of diseases, such as hypertension, diabetes, and metabolic syndrome, has been 
demonstrated previously. There have been studies concerning the relationship between 
vitamin D deficiency and cardiovascular diseases, which have shown different results. 
Therefore, this study aimed at determining the association between serum levels of 
vitamin D and acute coronary syndrome.
Methods: In this case-control study, serum levels of vitamin D were compared between 
50 patients with acute coronary syndrome and 50 individuals without this syndrome. 
A checklist, including demographic data of patients, comorbidities, vitamin D levels, 
lipid profiles, Electrocardiogram (ECG) changes and echocardiography results, was 
completed during hospitalization. 
Results: Mean age in the case and control group was 63.26 ± 10.76 and 61.22 ± 10.71 
years, respectively. The prevalence of diabetes and high blood pressure in the case group 
was 32% and 54% versus 10% and 8% in the control group, respectively. Overall, 70% 
and 18% of subjects were smokers in the control and case groups, respectively. Mean 
concentration of vitamin D in serum was 20.63 ± 13.90 ng/mL, which was significantly 
lower than the control group with a mean concentration of 29.54 ± 16.8 ng/mL (P-Value 
= 0.002). Finally, it was shown that for every one unit increase in vitamin D levels, the 
risk of acute coronary syndrome was reduced by 7% (P-Value = 0.005). 
Conclusions: The results of this study showed that the serum levels of vitamin D were 
significantly lower in patients with acute coronary syndrome compared to those without 
this disease.








Int J Cardiovasc Pract� 




Patients with cardiovascular disease, especially coronary ar-
tery disease (as the leading factor of high healthcare costs), 
comprise a significant number of patients admitted to hospi-
tals [1, 2]. Acute Coronary Syndrome (ACS) is a subgroup 
of coronary heart diseases, including ST-segment elevation 
myocardial infarction, non-ST-segment elevation myocardial 
infarction, and unstable angina [3, 4]. In addition to its high 
costs of hospitalization and treatment, ACS was considered 
as one of the most important causes of mortality and morbid-
ity in the recent years [5-7]. Similar to smoking, high choles-
terol and Low Density Lipoprotein (LDL), low High Density 
Lipoprotein (HDL), hypertension, diabetes and stress, and 
vitamin D Deficiency are among risk factors of cardiovascu-
lar diseases [6]. Vitamin D is synthesized in the skin from 
7-dehydrocholestrol through the activity of UV radiation,
and is converted to its active form of 1,25-dihydroxy vitamin 
D in the kidneys [8, 9]. Recent studies have shown that vita-
min D has receptors on vascular endothelium, smooth and
cardiac muscles, as well as a role in bone mineralization and
calcium transport in the intestine [10]. Vitamin D acts as a
protective factor against cardiac hypertrophy and myocardial 
dysfunction, and its deficiency has been demonstrated in dis-
eases, such as high blood pressure, diabetes, and metabolic
syndrome [11, 12]. The aim of this study was to investigate
the relationship between serum levels of vitamin D and acute 
coronary syndrome and its short-term effects, including car-
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diac arrhythmia and reduced left ventricular function. Ad-
ministration of vitamin D products could be considered to 
prevent coronary heart disease in case of a significant correla-
tion between vitamin D levels and ACS.
METHODS
In this study of case-control, conducted during years 2016 
to 2017, 50 patients with an age range of 40 to 80 years old 
admitted to the Coronary Care Unit (CCU), who were diag-
nosed with ACS (case group) and 50 non-cardiac patients, 
aged 40 to 80 years old from other wards of Mousavi Hospi-
tal of Zanjan (as the control group) were enrolled. After ob-
taining a license from the Ethics Committee of Zanjan Uni-
versity of Medical Sciences with the following code ZUMS.
REC.1393.108, a checklist involving demographic data of 
patients, including hypertension data, diabetes mellitus, hy-
perparathyroidism, smoking, consumption of vitamin D and 
calcium supplements in the past 3 months, ECG changes and 
echocardiography, were prepared and completed for patients 
during hospitalization. The patients consuming vitamin D- 
or calcium-containing compounds with a history of para-
thyroid disease were excluded. After providing the necessary 
explanations and obtaining written informed consent, 1 mL 
of fasting venous blood sample was drawn from patients to 
measure serum Vitamin D levels and lipid profile. Patients 
hospitalized for acute coronary syndrome was monitored for 
ECG changes, echocardiographic findings, and cardiac bio-
markers during hospitalization.
Statistical analysis
Continuous data are expressed as mean ± SD, and categorical 
variables as percentages. Simple random sampling was done 
by calculating the same sample size for both male and female 
groups. Continuous variables were compared by Student’s 
t-test and categorical variables were compared using the chi-
square test. The 2 groups were matched for age and gender. 
The effect of other confounding variables, including diabetes 
mellitus, hypertension, dyslipidemia, and smoking was even-
tually eliminated by logistic regression. Finally, the data were 
analyzed by the SPSS 20 software. All the statistical tests were 
calculated and assessed with a significance level of 0.05.
RESulTS
This study was conducted on 100 patients admitted to 
Mousavi Hospital of Zanjan, including 50 patients with 
ACS and 50 controls. The number of females and males in 
both groups was the same, with a mean age of 63.26 ± 10.76 
and 61.22 ± 10.71 years in the case and control groups, 
respectively. Mean level of vitamin D in the case and con-
trol groups was 20.63 ± 13.90 and 29.54 ± 16.80 ng/mL 
respectively, and mean difference in vitamin D levels was 
significant between the 2 groups (P = 0.002). A vitamin D 
level of less than 20 ng/mL was considered as Vitamin D 
deficiency [13-15]. Overall, 64% of cases and 34% of con-
trols had vitamin D deficiency (P = 0.011), which reflects 
the significance of vitamin D deficiency in both groups. 
Mean level of triglyceride, cholesterol, HDL, and LDL in 
cases were 166.52 ± 121.60, 195.19 ± 41.07, 41.06 ± 9.43, 
and 109.13 ± 28.42 versus 103.44 ± 59.20, 164.60 ± 38.26, 
43.66 ± 10.60, and 92.02 ± 29.67 mg/dL in controls, re-
spectively. Mean triglyceride and cholesterol levels were 
significantly higher in patients with ACS. Also, hyperten-
sion, diabetes, and smoking were significantly higher in the 
case group. Logistic regression model analysis was used to 
evaluate the impact of each effective factor on ACS with the 
elimination of other confounding factors. Based on the re-
sults, ACS risk was reduced by 7% per unit increase in vita-
min D levels (P = 0.005). Moreover, hypertension caused 
a 6.9-fold increase in the prevalence of ACS (P = 0.002). 
Smoking, in turn, caused a 10.4-fold increase in the risk of 
ACS (P = 0.001). Patients with ACS were evaluated by car-
diac continuous monitoring for cardiac arrhythmias. Evalu-
ations indicated cardiac arrhythmia in 10 patients including 
4 cases of sinus tachycardia, 1 sinus bradycardia, 3 cases of 
frequent Premature Ventricular Complex (PVC), 1 case of 
Atrial Fibrillation (AF) and 1 case of sustained Ventricular 
Tachycardia (VT). Mean vitamin D level in the patient with 
arrhythmia was 18.42 ± 9.11 ng/mL. Mean levels of vita-
min D in those lacking arrhythmia was 21.05 ± 14.91 ng/
mL, and the difference between vitamin D levels in the 2 
groups was not significant (P = 0.75). In addition, compar-
ison between mean levels of vitamin D at different Ejection 
Fraction (EF) levels showed no significant difference (P = 
0.39).
Table1: Demographic Data, and Mean Levels of Lipid Profile, Vitamin D, Hypertension, and Diabetes in the Case and Control Groups
Variable Case Control P� value
age(years) 63.26 ± 10.76 61.22 ± 10.71 -
Vitamin D( ng/ml) 20.63 ± 13.90 29.54 ± 16.80 0.002
TG(mg/dl) 166.52 ± 121.6 103.44 ± 59.20 0.002
Chol(mg/dl) 195.15 ± 41.07 164.60 ± 38.26 0.001
HDl(mg/dl) 41.06 ± 9.43 43.66 ± 10.60 0.21
lDl(mg/dl) 109.13 ± 28.42 92.02 ± 29.67 0.005
Diabetes 16(32%) 5(10%) 0.007
Hypertension 23(46%) 9(18%) 0.003
Smoking 35(70%) 6(12%) 0.02
Chol, Cholesterol; HDL, High Density Lipoprotein; LDL, Low Density Lipoprotein;  TG, Triglyceride
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Table 2: Estimation of Adjusted Odds Ratio of Factors Influencing ACS With Adjustment for Other Confounding Factors (CI = 95%)
Variables Case(n = 50) Control(n = 50) adjusted OR P� value
age(years) 63.26 ± 10.76 61.22 ± 10.71 1.05 0.084
Vitamin D( ng/ml) 20.63 ± 13.90 29.54 ± 16.80 0.939 0.005
TG(mg/dl) 166.52 ± 28.3 103.44 ± 14.8 1.002 0.62
Chol(mg/dl) 195.15 ± 36.2 164.60 ± 23.9 1.033 0.105
lDl(mg/dl) 109.13 ± 19.7 92.02 ± 18.1 0.98 0.380
Smoking 35(70%) 6(12%) 10.40 0.001
Diabetes 16(32%) 5(10%) 2.66 0.292
Hypertension 27(54%) 9(18%) 9.67 0.002
Chol, Cholesterol; LDL, Low density lipoprotein;  TG, Triglyceride; OR, Odds Ratio
Table 3: Mean Levels of Vitamin D According to Ejection Fraction and Cardiac Arrhythmia after Acute Coronary Syndrome
Variable Frequency(n = 50) Vitamin D (ng/ml) P�value
arrhythmia 10(20%) 22.65 ± 11.49 0.75
Ejection Fraction*
Mild  lVSD 19(38%) 18.64 ± 13.28
Moderate lVSD 22(44%) 24.43 ± 14.90 0.39
Severe  lVSD 9(18%) 18.42 ± 9.11
LVSD, Left Ventricular Systolic Dysfunction
*Normal LV Systolic Function: 60% ≤ EF 65% <, Mild LV Systolic Dysfunction: 60% > EF ≥ 45%, Moderate LV Systolic Dysfunction: 45% 
> EF ≥ 30%, Severe LV Systolic Dysfunction: EF < 30%
DISCuSSION
This case-control study was conducted to compare vitamin D 
levels in patients with and without ACS. According to the re-
sults of this study, mean levels of vitamin D were significantly 
lower in patients with ACS, and it was shown that for every 
one unit increase in vitamin D levels, the risk of ACS was re-
duced by 7%. However, no significant correlation was found 
between serum levels of vitamin D and short-term compli-
cations of ACS, including cardiac arrhythmias and reduced 
left ventricular function. The mechanism by which vitamin 
D exerts a protective effect against cardiovascular disease is 
not clear yet. The proposed mechanisms include effects on 
renin-angiotensin system and the prevention of high blood 
pressure, control of blood sugar by increasing sensitivity to 
insulin, a direct effect on calcium metabolism in cardiovas-
cular muscles, and an effect on the inflammatory system 
[16-18]. Similar to the current study, the majority of studies 
indicated the protective effect of vitamin D on cardiovascular 
disease, including ACS [14, 19-22]. In a number of studies, 
it was shown that a reduction in plasma levels of vitamin D 
was associated with the risk of ischemic heart disease, myo-
cardial infarction, and sudden death [11, 23-26]. However, in 
contrast to the current study, other studies did not indicate a 
significant relationship between serum vitamin D levels and 
the incidence of ACS, diabetes, hypertension, and smoking 
[27]. Other studies have even shown that the incidence of 
ACS is higher at higher levels of vitamin D, raising the need 
for further investigations to designate an optimum level of vi-
tamin D for the prevention of cardiovascular diseases [28]. 
In accordance with the function of the left ventricle, the ad-
ministration of vitamin D in people with vitamin D deficien-
cy significantly increased the EF value in one study, [29, 30] 
which indicates a significant relationship between ventricular 
dysfunction and vitamin D levels. Vitamin D appears to in-
fluence cardiac function through the synthesis of contractor 
proteins in cardiac myocytes, as well as regulation of calcium 
metabolism [31, 32]. Although no link was found between 
serum vitamin D levels with cardiac arrhythmia in the cur-
rent study, a number of studies have indicated vitamin D defi-
ciency as an independent risk factor for arrhythmia [33-35].
CONCluSIONS
This study suggests an independent link between serum vi-
tamin D levels and acute coronary syndrome, after adjusting 
for confounding factors. However, no significant relationship 
was found between the levels of vitamin D and short-term 
cardiac effects (e.g. arrhythmia and reduced left ventricular 
function), following acute coronary syndrome.
lIMITaTIONS
The most important limitation of this study was its small sam-
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ple size. In addition to the small number of patients, the study 
being conducted at a single should also be considered. Also, 
this study was designed to compare 2 groups of patients, ACS 
and non-cardiac diseases, thus the generalization of results 
should be done with caution.
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